tiprankstipranks
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX

Cumberland Pharmaceuticals Stock Analysis & Ratings

CPIX Stock Chart & Stats

Day’s Range$2.26 - $2.29
52-Week Range$2.17 - $7.51
Previous Close$2.25
Volume2.54K
Average Volume (3M)62.18K
Market Cap$35.02M
P/E Ratio-9.4
Beta0.30
Next EarningsAug 16, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score4
EPS (TTM)-0.24


Cumberland Pharmaceuticals News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CPIX FAQ

What was Cumberland Pharmaceuticals’s price range in the past 12 months?
Cumberland Pharmaceuticals lowest stock price was $2.17 and its highest was $7.51 in the past 12 months.
    What is Cumberland Pharmaceuticals’s market cap?
    Cumberland Pharmaceuticals’s market cap is $35.02M.
      What is Cumberland Pharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Cumberland Pharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      When is Cumberland Pharmaceuticals’s upcoming earnings report date?
      Cumberland Pharmaceuticals’s upcoming earnings report date is Aug 16, 2022 which is in 91 days.
        How were Cumberland Pharmaceuticals’s earnings last quarter?
        Cumberland Pharmaceuticals released its earnings results on May 10, 2022. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.09.
          Is Cumberland Pharmaceuticals overvalued?
          According to Wall Street analysts Cumberland Pharmaceuticals’s price is currently Overvalued.
            Does Cumberland Pharmaceuticals pay dividends?
            Cumberland Pharmaceuticals does not currently pay dividends.
            What is Cumberland Pharmaceuticals’s EPS estimate?
            Cumberland Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cumberland Pharmaceuticals have?
            Cumberland Pharmaceuticals has 14,840,000 shares outstanding.
              What happened to Cumberland Pharmaceuticals’s price movement after its last earnings report?
              Cumberland Pharmaceuticals reported an EPS of -$0.09 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.341%.
                Which hedge fund is a major shareholder of Cumberland Pharmaceuticals?
                Among the largest hedge funds holding Cumberland Pharmaceuticals’s share is Ariel Investments LLC. It holds Cumberland Pharmaceuticals’s shares valued at N/A.

                  ---

                  Cumberland Pharmaceuticals Stock Analysis

                  Smart Score
                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  Price Target
                  No data currently available
                  The Cumberland Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Cumberland Pharmaceuticals Inc

                  Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Hepatoren, Vaprisol, Boxaban, Vasculan, Ethyol, Portaban, and Totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Alimera
                  Prophase Labs
                  Cidara Therapeutics
                  Champions Oncology
                  Chembio Diagnostics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis